Another possible explanation of this diminished counterregulatory response to hypoglycemia in T1D may be the baseline hypersecretion of another hormone, somatostatin, and/or a greater activity of its receptors (23); such changes in somatostatin may also assist in explaining why even more glucagon is released when blood glucose levels are already elevated. This evidence concerns the gene SST and type 1 diabetes mellitus.